These CD36-dependent stromal characteristics can appear prior to, or in the absence of, a tumor, suggesting that activating a coordinated stromal program can be an early proactive event in the tumorigenic process rather than only a reactive response to tumor cell signals. This evidence concerns the gene CD36 and neoplasm.